As of December 31, 2025, Virbac SA carries a market capitalization of 3.69B, placing it among publicly traded companies globally. Its enterprise value stands at 3.89B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.69B |
| Enterprise Value | 3.89B |
Virbac SA's next confirmed earnings release is scheduled for March 23, 2027.
| Earnings Date | 3/23/2027 |
As of December 31, 2025, Virbac SA has 8.38M shares outstanding.
| Shares Outstanding | 8.38M |
These figures are as of December 31, 2025.
| PB Ratio | 2.79 |
| P/TBV Ratio | 5.84 |
As of December 31, 2025, Virbac SA maintains a current ratio of 1.53, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.53 |
| Quick Ratio | 0.24 |
| Debt / Equity | 25.67 |
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 6,031.00 |
As of the close on July 22, 2026, Virbac SA's stock has gained approximately 10.77% over the past 52 weeks.
| 52-Week Price Change | 10.77% |
| 50-Day Moving Average | 272.38 |
As of December 31, 2025, Virbac SA holds 143.93M in cash and equivalents against 339.36M in total debt, resulting in a net debt position of 149.64M. Total book value stands at 1.32B, with working capital of 323.79M providing operational flexibility.
| Cash & Cash Equivalents | 143.93M |
| Total Debt | 339.36M |
| Net Debt | 149.64M |
| Equity (Book Value) | 1.32B |
| Book Value Per Share | 157.80 |
| Working Capital | 323.79M |
Virbac SA's most recent stock split took place on July 30, 2002 with a 1:4 split ratio.
| Last Split Date | 7/30/2002 |
| Split Ratio | 1:4 |
Already premium?